Regulatory Science 541:
Drug Development, Reimbursement, and Marketing (3.0 units)
Survey of drug development strategies; health economics and outcomes researches and reimbursements; emphasis on coverage determination process and FDA and CMS parallel review process
Section | Session | Type | Time | Days | Registered | Instructor | Location | Syllabus | Info |
---|---|---|---|---|---|---|---|---|---|
49124D | 626 | Lecture | TBA | TBA | 16 of 50 | Chiaoyun Kuo, Frances Richmond, Eunjoo Pacifici,Michael Jamieson | OFFICE |